MwanzoNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
$ 1.95
Baada ya Saa za Kazi:(1.54%)+0.030
$ 1.98
Imefungwa: 2 Apr, 19:59:44 GMT -4 · USD · NYSEAMERICAN · Kanusho
Bei iliyotangulia
$ 1.59
Bei za siku
$ 1.57 - $ 1.98
Bei za mwaka
$ 1.11 - $ 99.75
Thamani ya kampuni katika soko
51.92M USD
Wastani wa hisa zilizouzwa
elfu 664.41
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu -521.00 | -122.56% |
Matumizi ya uendeshaji wa biashara | 1.78M | 0.79% |
Mapato halisi | -26.60M | -2,094.39% |
Kiwango cha faida halisi | elfu 5.10 | — |
Mapato kwa kila hisa | — | — |
EBITDA | -1.82M | -3.52% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 7.96M | 1,750.70% |
Jumla ya mali | 9.04M | 163.95% |
Jumla ya dhima | 31.86M | 796.99% |
Jumla ya hisa | -22.83M | — |
hisa zilizosalia | 26.63M | — |
Uwiano wa bei na thamani | -1.73 | — |
Faida inayotokana na mali | -72.83% | — |
Faida inayotokana mtaji | 46.90% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -26.60M | -2,094.39% |
Pesa kutokana na shughuli | -2.29M | -170.40% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | 7.82M | 1,463.20% |
Mabadiliko halisi ya pesa taslimu | 5.52M | 1,696.24% |
Mtiririko huru wa pesa | -1.47M | -89.55% |
Kuhusu
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Ilianzishwa
2000
Makao Makuu
Tovuti
Wafanyakazi
3
